1. Efficacy and Safety of Anti-PD-1/ PD-L1 Monotherapy for Metastatic Breast Cancer: Clinical Evidence
   Yihang Qi et al, 2021, Frontiers in Pharmacology CrossRef
2. Targeting molecular cross-talk between tumor cells and tumor associated macrophage as therapeutic strategy in triple negative breast cancer
   Anusha Shettigar et al, 2023, International Immunopharmacology CrossRef
3. Single peptides and combination modalities for triple negative breast cancer
   Atefeh Razazan et al, 2020, Journal of Cellular Physiology CrossRef
4. Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives
   Karima Oualla et al, 2020, International Journal of Breast Cancer CrossRef